XTX Topco Ltd Sells 211,541 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

XTX Topco Ltd lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 63.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 122,428 shares of the pharmacy operator's stock after selling 211,541 shares during the quarter. XTX Topco Ltd's holdings in Walgreens Boots Alliance were worth $1,142,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. First Financial Corp IN lifted its position in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after acquiring an additional 885 shares during the period. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $26,000. Riverview Trust Co boosted its holdings in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter worth about $28,000. Finally, TD Private Client Wealth LLC raised its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

WBA traded down $0.06 during trading on Monday, reaching $10.84. The stock had a trading volume of 1,240,450 shares, compared to its average volume of 21,000,235. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $18.83. The firm has a market capitalization of $9.37 billion, a price-to-earnings ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The stock has a 50 day moving average of $10.85 and a two-hundred day moving average of $10.15. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. The business had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.20 earnings per share. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

WBA has been the topic of a number of research analyst reports. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a report on Saturday. They set a "hold" rating on the stock. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their target price for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.